Drug safety evaluation of dronedarone in atrial fibrillation

Author： De Ferrari Gaetano M Dusi Veronica

ISSN： 1474-0338

Source： Expert Opinion on Drug Safety, Vol.11, Iss.6, 2012-11, pp. : 1023-1045

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Dronedarone rates highly for atrial fibrillation

Inpharma, Vol. 1, Iss. 1456, 2004-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Dronedarone: a guide to its use in atrial fibrillation

Drugs & Therapy Perspectives, Vol. 26, Iss. 3, 2010-03 ,pp. : 1-5

Adis International

Access to resources Recommend Favorite

Dronedarone: A New Hope for Stroke Prevention in Atrial Fibrillation?

By Shantsila Alena Lip Gregory Y.H.

American Journal of Cardiovascular Drugs, Vol. 11, Iss. 6, 2011-12 ,pp. : 355-356

Adis International

Access to resources Recommend Favorite

PALLAS: limiting indications for dronedarone treatment of atrial fibrillation?

By Doggrell Sheila A Hancox Jules C

Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 6, 2012-04 ,pp. : 867-871

Informa Healthcare

Access to resources Recommend Favorite

Dronedarone for the Treatment of Atrial Fibrillation: A NICE Single Technology Appraisal

By McKenna Claire

PharmacoEconomics, Vol. 30, Iss. 1, 2012-01 ,pp. : 35-46

Adis International

Access to resources Recommend Favorite